Arca
Skip to content
Tools
Tools

Conopco Inc. d/b/a Unilever

FDA establishment 1047784, Raeford, North Carolina, United States. Every inspection FDA has posted for the site, with its outcome and cited regulations.

  • Inspections: 3
  • Official action indicated: 1
  • Last inspection ended: Jul 13, 2026
  • Warning letters: 0

Inspections by Fiscal Year

FY2018 to FY2027 to date; 1 classified OAI

Most Cited at This Site

Inspections citing each reference

Inspections

3 inspections, newest first
EndedProduct and areaCitationsClassification
Jul 13, 2026Drugs · Drug Quality Assurance
5 cited references
  • 21 CFR 211.22(d). Procedures not in writing, fully followed The responsibilities and procedures applicable to the quality control unit are not in writing and fully followed.
  • 21 CFR 211.182. Written records kept in individual logs Written records of major equipment maintenance and use are not included in individual equipment logs.
  • 21 CFR 211.67(b). Written procedures not established/followed Written procedures are not established and followed for the cleaning and maintenance of equipment, including utensils, used in the manufacture, processing, packing or holding of a drug product.
  • 21 CFR 211.170(b). Annual visual exams of drug products Reserve samples from representative sample lots or batches of drug products selected by acceptable statistical procedures are not examined visually at least once a year for evidence of deterioration.
  • 21 CFR 211.67(a). Cleaning / Sanitizing / Maintenance Equipment and utensils are not maintained at appropriate intervals to prevent malfunctions and contamination that would alter the safety, identity, strength, quality or purity of the drug product.
Official Action Indicated (OAI)
May 27, 2022Drugs · Drug Quality AssuranceNone postedVoluntary Action Indicated (VAI)
Sep 16, 2016Drugs · Drug Quality Assurance
3 cited references
  • 21 CFR 211.160(b)(4). Calibration - at intervals, written program, remedial action The calibration of instruments is not done at suitable intervals with provisions for remedial action in the event accuracy and/or precision limits are not met.
  • 21 CFR 211.22(d). Procedures not in writing, fully followed The responsibilities and procedures applicable to the quality control unit are not fully followed.
  • 21 CFR 211.192. No written record of investigation Written records are not always made of investigations into the failure of a batch or any of its components to meet specifications.
Voluntary Action Indicated (VAI)

Identifiers

FEI number
1047784
FDA firm profile
Data Dashboard

An FEI (FDA Establishment Identifier) names one physical site. Inspections, outcomes and citations come from FDA's Data Dashboard; FDA posts citations only for some inspections. A contract site can make products for many companies, so the company shown is the one FDA lists as the site's firm. FDA Data Dashboard and warning letters

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.